Viking Therapeutics

Viking Therapeutics

VKTX· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -12.6% in FY2025

Brian Lian, Ph.D. is the CEO of Viking Therapeutics and was paid $21.3M in FY2025 (Dec), up 49%.

Pay$100 in the stock at the end of FY21 → $765
CEO pay is from each Viking Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Brian Lian, Ph.D.FY2025
  2. 2Marianne ManciniFY2025
  3. 3Greg ZanteFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Viking Therapeutics paid its 3 named executives $31.6M in total in FY2025 (Dec). CEO Brian Lian, Ph.D. was paid $21.3M of that.

Name
Brian Lian, Ph.D.Chief Executive Officer
Marianne ManciniChief Operating Officer
Greg ZanteChief Financial Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers18

See all

The FY2025 (Dec) proxy of Viking Therapeutics names 18 peer companies for pay. Among Viking Therapeutics and these peers, CEO pay was the highest of 8 and total shareholder return was the highest of 8.

1st highest of 8in Viking Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:

$10.4M$21.3M

1st highest of 8in Viking Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:

$108$625

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board1

See all
  • S. Kathryn Rouan, Ph.D.Director · 6 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive

The board of the latest proxy (FY2025).

Activity

Filings6

See all
Proxy statementDEF 14AApr 1, 2026FY2025
Annual report10-KFeb 11, 2026FY2025
Proxy statementDEF 14AApr 8, 2025FY2024
Annual report10-KFeb 26, 2025FY2024
Proxy statementDEF 14AApr 5, 2024FY2023
Annual report10-KFeb 7, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data